Telomere stability and telomerase in mesenchymal stem cells

Biochimie

Volumn 90, Issue 1, 2008, Pages 33-40

  Serakinci, Nedime ^a,b   Graakjaer, Jesper ^b   Kolvraa, Steen ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Mesenchymal stem cells; Stem cells; Telomerase; Telomere homeostasis

Indexed keywords

TELOMERASE;

EPIGENETICS; GENE CONTROL; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TELOMERE;

ADULT STEM CELLS; CELL AGING; CELL DIVISION; EPIGENESIS, GENETIC; HUMANS; MESENCHYMAL STEM CELLS; TELOMERASE; TELOMERE;

EID: 36749064910     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2007.09.005     Document Type: Review

References (106)

1. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
2. Henderson E.R., and Blackburn E.H. An overhanging 3′ terminus is a conserved feature of telomeres. Mol. Cell Biol. 9 (1989) 345-348
3. de Lange T. Protection of mammalian telomeres. Oncogene 21 (2002) 532-540
4. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., et al. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
5. Stansel R.M., de Lange T., and Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20 (2001) 5532-5540
6. Stansel R.M., Subramanian D., and Griffith J.D. p53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem. 277 (2002) 11625-11628
7. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
8. Harley C.B., Vaziri H., Counter C.M., and Allsopp R.C. The telomere hypothesis of cellular aging. Exp. Gerontol. 27 (1992) 375-382
9. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., and Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346 (1990) 866-868
10. von Zglinicki T., Saretzki G., Docke W., and Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res. 220 (1995) 186-193
11. Dionne I., and Wellinger R.J. Cell cycle-regulated generation of single-stranded G-rich DNA in the absence of telomerase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13902-13907
12. Hemann M.T., and Greider C.W. G-strand overhangs on telomeres in telomerase-deficient mouse cells. Nucleic Acids Res. 27 (1999) 3964-3969
13. Blackburn E.H., Greider C.W., Henderson E., Lee M.S., Shampay J., and Shippen-Lentz D. Recognition and elongation of telomeres by telomerase. Genome 31 (1989) 553-560
14. Greider C.W., and Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51 (1987) 887-898
15. Dhaene K., Van Marck E., and Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Arch. 437 (2000) 1-16
16. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155 (1995) 3711-3715
17. Smogorzewska A., and de Lange T. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73 (2004) 177-208
18. Cross S.H., Allshire R.C., McKay S.J., McGill N.I., and Cooke H.J. Cloning of human telomeres by complementation in yeast. Nature 338 (1989) 771-774
19. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10114-10118
20. Bekaert S., Derradji H., and Baatout S. Telomere biology in mammalian germ cells and during development. Dev. Biol. 274 (2004) 15-30
21. Frenck Jr. R.W., Blackburn E.H., and Shannon K.M. The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5607-5610
22. Rufer N., Dragowska W., Thornbury G., Roosnek E., and Lansdorp P.M. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol. 16 (1998) 743-747
23. Rufer N., Brummendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 190 (1999) 157-167
24. Counter C.M., Hirte H.W., Bacchetti S., and Harley C.B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2900-2904
25. de Lange T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2882-2885
26. Carpenter M.K., Rosler E.S., Fisk G.J., Brandenberger R., Ares X., Miura T., et al. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev. Dyn. 229 (2004) 243-258
27. Brummendorf T.H., and Balabanov S. Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover. Leukemia 20 (2006) 1706-1716
28. Hiyama E., and Hiyama K. Telomere and telomerase in stem cells. Br. J. Cancer. 96 (2007) 1020-1024
29. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
30. Prowse K.R., and Greider C.W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4818-4822
31. Reddel R.R. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett. 194 (2003) 155-162
32. Reddel R.R., and Bryan T.M. Alternative lengthening of telomeres: dangerous road less travelled. Lancet 361 (2003) 1840-1841
33. Serakinci N., Christensen R., Graakjaer J., Cairney C.J., Keith W.N., Alsner J., et al. Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart. Exp. Cell Res. 313 (2007) 1056-1067
34. Graakjaer J., Christensen R., Kolvraa S., and Serakinci N. Mesenchymal stem cells with high telomerase expression do not actively restore their chromosome arm specific telomere length pattern after exposure to ionizing radiation. BMC Mol. Biol. 8 (2007) 49
35. Karpowicz P., Morshead C., Kam A., Jervis E., Ramuns J., Cheng V., et al. Support for the immortal strand hypothesis: neural stem cells partition DNA asymmetrically in vitro. J. Cell Biol. 170 (2005) 721-732
36. Shinin V., Gayraud-Morel B., Gomes D., and Tajbakhsh S. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat. Cell Biol. 8 (2006) 677-U69
37. Cairns J. Cancer and the immortal strand hypothesis. Genetics 174 (2006) 1069-1072
38. Serakinci N., Hoare S.F., Kassem M., Atkinson S.P., and Keith W.N. Telomerase promoter reprogramming and interaction with general transcription factors in the human mesenchymal stem cell. Regen. Med. 1 (2006) 125-131
39. Braun K.M., Niemann C., Jensen U.B., Sundberg J.P., Silva-Vargas V., and Watt F.M. Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in whole mounts of mouse epidermis. Development 130 (2003) 5241-5255
40. Ito H., Kyo S., Kanaya T., Takakura M., Inoue M., and Namiki M. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res. 4 (1998) 1603-1608
41. Elkak A., Mokbel R., Wilson C., Jiang W.G., Newbold R.F., and Mokbel K. hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer. Anticancer Res. 26 (2006) 4901-4904
42. Horikawa I., and Barrett J.C. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24 (2003) 1167-1176
43. Liu L., Lai S., Andrews L.G., and Tollefsbol T.O. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 340 (2004) 1-10
44. Tam W.L., Ang Y.S., and Lim B. The molecular basis of ageing in stem cells. Mech. Ageing Dev. 128 (2007) 137-148
45. Serakinci N., Guldberg P., Burns J.S., Abdallah B., Schrodder H., Jensen T., et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23 (2004) 5095-5098
46. Baumann P., and Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292 (2001) 1171-1175
47. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., and Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17 (1997) 236-239
48. Broccoli D., Smogorzewska A., Chong L., and de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17 (1997) 231-235
49. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P., et al. A human telomeric protein. Science 270 (1995) 1663-1667
50. Houghtaling B.R., Cuttonaro L., Chang W., and Smith S. A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr. Biol. 14 (2004) 1621-1631
51. Kim S.H., Kaminker P., and Campisi J. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23 (1999) 405-412
52. Li B., Oestreich S., and de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 101 (2000) 471-483
53. Zhong Z., Shiue L., Kaplan S., and de Lange T. A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol. Cell Biol. 12 (1992) 4834-4843
54. Benetti R., Garcia-Cao M., and Blasco M.A. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39 (2007) 243-250
55. Blasco M.A. Carcinogenesis Young Investigator Award. Telomere epigenetics: a higher-order control of telomere length in mammalian cells. Carcinogenesis 25 (2004) 1083-1087
56. Garcia-Cao M., O'Sullivan R., Peters A.H., Jenuwein T., and Blasco M.A. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 36 (2004) 94-99
57. Gonzalo S., Jaco I., Fraga M.F., Chen T.P., Li E., Esteller M., et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8 (2006) 416-U66
58. Oganesian L., and Bryan T.M. Physiological relevance of telomeric G-quadruplex formation: a potential drug target. Bioessays 29 (2007) 155-165
59. Blasco M.A. The epigenetic regulation of mammalian telomeres. Nat. Rev. Genet. 8 (2007) 299-309
60. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11 (1992) 1921-1929
61. Ouellette M.M., McDaniel L.D., Wright W.E., Shay J.W., and Schultz R.A. The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum. Mol. Genet. 9 (2000) 403-411
62. Raouf A., Brown L., Vrcelj N., To K., Kwok W., Huntsman D., et al. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY. J. Natl. Cancer Inst. 97 (2005) 1302-1306
63. Schreurs M.W.J., Hermsen M.A.J.A., Geltink R.I.K., Scholten K.B.J., Brink A.A.T.P., Kueter E.W.M., et al. Genomic stability and functional activity may be lost in telomerase-transduced human CD8(+) T lymphocytes. Blood 106 (2005) 2663-2670
64. Atkinson S.P., Hoare S.F., Glasspool R.M., and Keith W.N. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 65 (2005) 7585-7590
65. Gonzalo S., Garcia-Cao M., Fraga M.F., Schotta G., Peters A.H.F.M., Cotter S.E., et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol. 7 (2005) 420-U52
66. Ulaner G.A., Huang H.Y., Otero J., Zhao Z., Ben Porat L., Satagopan J.M., et al. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res. 63 (2003) 1759-1763
67. Johnson J.E., Varkonyi R.J., Schwalm J., Cragle R., Klein-Szanto A., Patchefsky A., et al. Multiple mechanisms of telomere maintenance exist in liposarcomas. Clin. Cancer Res. 11 (2005) 5347-5355
68. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 20 (2002) 592-596
69. Kanatsu-Shinohara M., Ogonuki N., Iwano T., Lee J., Kazuki Y., Inoue K., et al. Genetic and epigenetic properties of mouse male germline stem cells during long-term culture. Development 132 (2005) 4155-4163
70. Allsopp R.C., Morin G.B., Horner J.W., DePinho R., Harley C.B., and Weissman I.L. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat. Med. 9 (2003) 369-371
71. Graakjaer J., Bischoff C., Korsholm L., Holstebroe S., Vach W., Bohr V.A., et al. The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech. Ageing Dev. 124 (2003) 629-640
72. Lansdorp P.M., Verwoerd N.P., van de Rijke F.M., Dragowska V., Little M.T., Dirks R.W., et al. Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet. 5 (1996) 685-691
73. Londono-Vallejo J.A., DerSarkissian H., Cazes L., and Thomas G. Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res. 29 (2001) 3164-3171
74. Martens U.M., Zijlmans J.M., Poon S.S., Dragowska W., Yui J., Chavez E.A., et al. Short telomeres on human chromosome 17p. Nat. Genet. 18 (1998) 76-80
75. Graakjaer J., Pascoe L., Der-Sarkissian H., Thomas G., Kolvraa S., Christensen K., et al. The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell 3 (2004) 97-102
76. Graakjaer J., Der-Sarkissian H., Schmitz A., Bayer J., Thomas G., Kolvraa S., et al. Allele-specific relative telomere lengths are inherited. Hum. Genet. 119 (2006) 344-350
77. Passegue E., Jamieson C.H., Ailles L.E., and Weissman I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc. Natl. Acad. Sci. U.S.A. 100 1 (2003) 11842-11849
78. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 15178-15183
79. Al Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3983-3988
80. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
81. Zeng X., and Rao M.S. Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience 145 (2007) 1348-1358
82. Zimmermann S., Voss M., Kaiser S., Kapp U., Waller C.F., and Martens U.M. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17 (2003) 1146-1149
83. Izadpanah R., Trygg C., Patel B., Kriedt C., Dufour J., Gimble J.M., et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell. Biochem. 99 (2006) 1285-1297
84. Wright L.S., Prowse K.R., Wallace K., Linskens M.H.K., and Svendsen C.N. Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp. Cell Res. 312 (2006) 2107-2120
85. Maurelli R., Zambruno G., Guerra L., Abbruzzese C., Dimri G., Gellini M., et al. Inactivation of p16(INK4a) (inhibitor of cyclin-dependent kinase 4A) immortalizes primary human keratinocytes by maintaining cells in the stem cell compartment. FASEB J. 20 (2006) 1516-1518
86. Fajkus J., Borsky M., Kunicka Z., Kovarikova M., Dvorakova D., Hofmanova J., et al. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells. Anticancer Res. 23 (2003) 1605-1612
87. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436 (2005) 1048-1052
88. Hoogduijn M.J., Gorjup E., and Genever P.G. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 15 (2006) 49-60
89. Suwa T., Yang L., and Hornsby P.J. Telomerase activity in primary cultures of normal adrenocortical cells. J. Endocrinol. 170 (2001) 677-684
90. Chen M., Hawks C.L., Huang Q., Sun B., and Hornsby P.J. Telomerase is not required for experimental tumorigenesis of human and bovine adrenocortical cells. Endocr. Res. 30 (2004) 555-565
91. Sun B., Huang Q., Liu S., Chen M., Hawks C.L., Wang L., et al. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase. Cancer Res. 64 (2004) 6144-6151
92. Moriscot C., de Fraipont F., Richard M.J., Marchand W., Savatier P., Bosco D., et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 23 (2005) 594-603
93. Lin S.Y., and Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 (2003) 881-889
94. Takakura M., Kyo S., Inoue M., Wright W.E., and Shay J.W. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol. Cell. Biol. 25 (2005) 8037-8043
95. Zhao J., Bilsland A., Jackson K., and Keith W.N. MDM2 negatively regulates the human telomerase RNA gene promoter. BMC Cancer 5 (2005) 6
96. Li H., Lee T.H., and Avraham H. A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J. Biol. Chem. 277 (2002) 20965-20973
97. Fujimoto K., Kyo S., Takakura M., Kanaya T., Kitagawa Y., Itoh H., et al. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res. 28 (2000) 2557-2562
98. Gunes C., Lichtsteiner S., Vasserot A.P., and Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res. 60 (2000) 2116-2121
99. Gabet A.S., Mortreux F., Charneau P., Riou P., Duc-Dodon M., Wu Y., et al. Inactivation of hTERT transcription by Tax. Oncogene 22 (2003) 3734-3741
100. Chang J.T., Yang H.T., Wang T.C., and Cheng A.J. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Mol. Carcinog. 44 (2005) 183-192
101. Won J., Yim J., and Kim T.K. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J. 16 (2002) 1943-1945
102. Konnikova L., Simeone M.C., Kruger M.M., Kotecki M., and Cochran B.H. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65 (2005) 6516-6520
103. Endoh T., Tsuji N., Asanuma K., Yagihashi A., and Watanabe N. Survivin enhances telomerase activity via up-regulation of specificity protein 1-and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp. Cell Res. 305 (2005) 300-311
104. Kimura A., Ohmichi M., Kawagoe J., Kyo S., Mabuchi S., Takahashi T., et al. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23 (2004) 4505-4515
105. Goueli B.S., and Janknecht R. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22 (2003) 8042-8047
106. Won J., Yim J., and Kim T.K. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J. Biol. Chem. 277 (2002) 38230-38238